Cathie Wood's Ark Invest sold shares in UiPath, Prime Medicine, and Repare Therapeutics, with notable gains and losses.

Despite a 20% stock decline, we maintain a bullish view on UiPath due to its strategic pivot to Agentic AI and strong ...

Leading CISOs honored for leadership, security, and business impact SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) -- The 2025 ...

Learn more about whether UiPath Inc. or Qualys, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Asana, Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare ...

Cathie Wood’s ARK ETFs have made their latest round of daily trades for Wednesday, April 9th, 2025, continuing to adjust their positions in a variety of companies across their funds. The most ...

UiPath (NYSE:PATH) recently launched its AI-based Medical Record Summarization Agent at the Google Cloud Next 2025 event, emphasizing efficiency and cost savings in healthcare. Despite these promising ...

UiPath shares rise on launch of generative AI-based UiPath Medical Record Summarization agent at Google Cloud Next 2025.

Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this ...

Both APP and PATH are technology companies leveraging artificial intelligence to enhance their platforms. Which one is a ...

UiPath (PATH) announced at Google Cloud Next 2025 the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by ...

UiPath announced the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by Google Cloud ...